We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
988

Sector Composition

Rank Sector Weight
1 Technology 6.22%
2 Financials 6.16%
3 Industrials 5.09%
4 Consumer Discretionary 4.89%
5 Healthcare 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMKR icon
7001
CALL
Amkor Technology
AMKR
$14.7B
$184K ﹤0.01%
18,300
-3,300
-15% -$35.3K
CLMT icon
7002
CALL
Calumet Specialty Products
CLMT
$4.19B
$184K ﹤0.01%
23,900
-6,300
-21% -$52.5K
FENG
7003
Phoenix New Media
FENG
$18.1M
$184K ﹤0.01%
+4,727
New +$176K
IDT icon
7004
PUT
IDT Corp
IDT
$1.66B
$184K ﹤0.01%
+20,567
New +$225K
LUMO
7005
CALL
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$184K ﹤0.01%
2,522
-845
-25% -$69.9K
RPT
7006
PUT
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$184K ﹤0.01%
+12,500
New +$173K
REGI
7007
DELISTED
Renewable Energy Group, Inc.
REGI
$184K ﹤0.01%
15,601
-3,452
-18% -$39.9K
NSU
7008
PUT
DELISTED
Nevsun Resources Ltd.
NSU
$184K ﹤0.01%
75,600
+15,400
+26% +$35.6K
GORO icon
7009
Goldgroup Mining Inc.
GORO
$207M
$183K ﹤0.01%
41,460
+4,721
+13% +$18.5K
GSS
7010
DELISTED
Golden Star Resources Ltd.
GSS
$183K ﹤0.01%
41,114
+36,596
+810% +$148K
TAHO
7011
CALL
DELISTED
Tahoe Resources Inc
TAHO
$183K ﹤0.01%
38,300
-6,400
-14% -$30.1K
OMED
7012
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$183K ﹤0.01%
44,578
+10,991
+33% +$47.8K
VNDA icon
7013
PUT
Vanda Pharmaceuticals
VNDA
$316M
$182K ﹤0.01%
+12,000
New +$178K
WPRT
7014
CALL
Westport Fuel Systems
WPRT
$33.4M
$182K ﹤0.01%
4,830
+710
+17% +$23.1K
ABEO icon
7015
PUT
Abeona Therapeutics
ABEO
$341M
$181K ﹤0.01%
456
-24
-5% -$9.93K
CORN icon
7016
PUT
Teucrium Corn Fund
CORN
$171M
$181K ﹤0.01%
10,800
-3,500
-24% -$59.7K
RAIL icon
7017
PUT
FreightCar America
RAIL
$240M
$181K ﹤0.01%
+10,600
New +$183K
RFP
7018
CALL
DELISTED
Resolute Forest Products Inc.
RFP
$181K ﹤0.01%
+16,400
New +$133K
CHI
7019
Calamos Convertible Opportunities and Income Fund
CHI
$1.07B
$180K ﹤0.01%
+16,107
New +$185K
TRIL
7020
DELISTED
Trillium Therapeutics Inc.
TRIL
$180K ﹤0.01%
+24,622
New +$204K
ORBC
7021
PUT
DELISTED
ORBCOMM, Inc.
ORBC
$180K ﹤0.01%
+17,700
New +$187K
BKS
7022
CALL
DELISTED
Barnes & Noble
BKS
$179K ﹤0.01%
26,700
-3,600
-12% -$25.5K
KEG
7023
DELISTED
Key Energy Services, Inc. Common Stock
KEG
$179K ﹤0.01%
+15,171
New +$168K
IAU icon
7024
iShares Gold Trust
IAU
$64.9B
$178K ﹤0.01%
+7,100
New +$174K
MRCC
7025
DELISTED
Monroe Capital Corp
MRCC
$178K ﹤0.01%
12,922
+2,855
+28% +$40.9K

Similar funds

Ken Griffin's Q4 2017 Portfolio in Review

As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
  • Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.